TickerFacts.

Company research / BHC

Bausch Health Companies Inc. (BHC)

Build a valuation ↗↓ Download CSV

CIK 0000885590 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NJ
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Bausch Health Companies Inc. reported revenue of $10.27B. Revenue grew 6.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $10.85B.

Key ratios (year ended 2025-12-31)

17.7%
Operating margin
1.2%
Net margin
31.8%
Return on year-end equity
6.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$10.85B$10.27B$9.62B$8.76B$8.12B$8.43B$8.03B$8.60B$8.38B$8.72B$9.67B
Cost of Revenuen/an/an/an/an/an/an/an/an/a$2.51B$2.57B
Gross Profit (computed)n/an/an/an/an/an/an/an/an/a$6.22B$7.10B
R&D Expense$663.00M$629.00M$616.00M$604.00M$529.00M$465.00M$452.00M$471.00M$413.00M$361.00M$421.00M
Operating Income$883.00M$1.81B$1.55B$963.00M$454.00M$450.00M$676.00M-$203.00M-$2.38B$102.00M-$566.00M
Depreciation & Amortization$1.17B$1.21B$1.27B$1.26B$1.39B$1.55B$1.82B$2.08B$2.82B$2.86B$2.87B
EBITDA$2.06B$3.02B$2.81B$2.23B$1.85B$2.00B$2.50B$1.87B$435.00M$2.96B$2.30B
Net Income-$1.09B$120.00M-$72.00M-$611.00M-$212.00M-$937.00M-$559.00M-$1.78B-$4.14B$2.40B-$2.41B
EPS (Diluted)n/a$0.42-$0.13-$1.62-$0.62-$2.64-$1.58-$5.08-$11.81$6.83-$6.94
Total Assets$24.79B$26.37B$26.52B$27.35B$25.69B$29.20B$31.20B$33.86B$32.49B$37.50B$43.53B
Total Liabilities$25.60B$25.99B$26.84B$27.43B$25.43B$29.24B$30.59B$32.73B$29.68B$31.55B$40.27B
Long-Term Debt$20.74B$20.82B$21.62B$22.39B$20.77B$22.65B$23.93B$25.89B$24.30B$25.44B$29.85B
Shareholders' Equity-$802.00M$377.00M-$322.00M-$82.00M$260.00M-$34.00M$605.00M$1.14B$2.81B$5.94B$3.26B
Cash & Equivalents$1.82B$1.31B$1.18B$947.00M$564.00M$582.00M$605.00M$3.24B$721.00M$720.00M$542.00M
Operating Cash Flow$1.80B$1.40B$1.60B$1.03B-$728.00M$1.43B$1.11B$1.50B$1.50B$2.29B$2.09B
Capital Expenditures$369.00M$397.00M$337.00M$215.00M$218.00M$269.00M$302.00M$270.00M$157.00M$171.00M$235.00M
Free Cash Flow$1.43B$1.00B$1.26B$817.00M-$946.00M$1.16B$809.00M$1.23B$1.34B$2.12B$1.85B
Share Repurchasesn/an/an/an/an/an/an/an/an/a$0$0
Shares Outstanding373.90M370.53M367.84M365.24M361.90M359.41M355.42M352.56M349.87M348.71M347.82M
Weighted Average Diluted Sharesn/a375.00M368.00M364.90M362.00M358.90M355.00M352.10M351.30M351.80M347.30M
EPS (Basic)n/a$0.42-$0.13-$1.62-$0.62-$2.64-$1.58-$5.08-$11.81$6.86-$6.94

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView